Clinical significance of the augmentation index in patients with preserved kidney function

Journal of Nippon Medical School

Volumn 79, Issue 6, 2012, Pages 422-429

  Hitsumoto, Takashi ^a  

^a Hitsumoto Medical Clinic   (Japan)

Author keywords

Augmentation index; Inflammation; Oxidative stress; Preserved kidney function; Urinary albumin concentration

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTAGLANDIN F2 ALPHA; TRIACYLGLYCEROL;

AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD PRESSURE; BODY HEIGHT; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; SMOKING; TONOMETRY;

EID: 84871438579     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.79.422     Document Type: Article

References (28)

1. Coresh J, Selvin E, Stevens LA, et al.: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Yamagata K, Ishida K, Sairenchi T, et al.: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159-166.
3. Curhan GC: Prediabetes, prehypertension... is it time for pre-CKD? Clin J Am Soc Nephrol 2010; 5: 557-559.
4. Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A: Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res 2007; 30: 219-228.
5. Williams B, Lacy PS, Thom SM, et al.: CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
6. Roman MJ, Devereux RB, Kizer JR, et al.: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50: 197-203.
7. London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438.
8. Otsuka T, Kawada T, Ibuki C, Kusama Y: Radial arterial wave reflection is associated with the MEGA risk prediction score, an indicator of coronary heart disease risk, in middle-aged men with mild to moderate hypercholesterolemia. J Atheroscler Thromb 2010; 17: 688-694.
9. Kohara K, Tabara Y, Oshiumi A, Miyawaki K, Kobayashi T, Miki T: Radial augmentation index: a useful and easily obtainable parameter for vascular aging. Am J Hypertens 2005; 18: 11S-14S.
10. Imai E, Horio M, Nitta K, et al.: Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11: 41-50.
11. Fridewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
13. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006; 13: 101-107.
14. Ninomiya T, Kiyohara Y, Tokuda Y, et al.: Japan Arteriosclerosis Longitudinal Study Group: Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 2008; 118: 2694-2701.
15. Gerstein HC, Mann JF, Yi Q, et al.: HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
16. Arnlöv J, Evans JC, Meigs JB, et al.: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975.
17. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323.
18. Oliver JJ, Webb DJ: Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thrombs Vasc Biol 2003; 23: 554-566.
19. Soga J, Nakamura S, Nishioka K, et al.: Relationship between augmentation index and flow-mediated vasodilation in the brachial artery. Hypertens Res 2008; 31: 1293-1298.
20. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
21. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
22. Kondo T, Hirose M, Kageyama K: Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 2009; 16: 532-538.
23. Booth AD, Wallace S, McEniery CM, et al.: Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004; 50: 581-588.
24. Spence VA, Kennedy G, Belch JJ, Hill A, Khan F: Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. Clin Sci (Lond) 2008; 114: 561-566.
25. Klingbeil AU, John S, Schneider MP, Jacobi J, Weidinger G, Schmieder RE: AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens 2002; 20: 2423-2428.
26. Murgo JP, Westerhof N, Giolma JP, Altobelli SA: Aortic input impedance in normal man: relationship to pressure wave forms. Circulation 1980; 62: 105-116.
27. Kinlay S, Schwartz GG, Olsson AG, et al.: Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators: High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003; 108: 1560-1566.
28. Hirooka Y, Kimura Y, Sagara Y, Ito K, Sunagawa K: Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension. Clin Exp Hypertens 2008; 3: 267-276.